Even as Europe's medicines watchdog declared there was no evidence to back a health warning, France insisted on restricting the prescription of newer-generation birth control pills.
Birth Control Pills | Contraceptive Pills Types Advantages Side Effects & Risks
Oral contraceptive or birth control pills contain hormones that prevent pregnancy. It is one of the most reliable methods of contraception.
Oral contraceptive or birth control pills contain hormones that prevent pregnancy. It is one of the most reliable methods of contraception.
"The objective is that these pills are no longer prescribed to women as a first option," she said in a statement.
But the EMA earlier said it saw no need to change guidelines.
Birth Control Patch – How to Use, Advantages and Disadvantages
A birth control patch is a new method of contraception for women for once weekly external application and contains both estrogen and progesterone.
A birth control patch is a new method of contraception for women for once weekly external application and contains both estrogen and progesterone.
"Therefore, there is no reason for any woman to stop using her contraception."
Advertisement
Banned Drugs | Drugs Banned in India | List of Banned Drugs
Several drugs are either banned or withdrawn after introduction in the market.
Several drugs are either banned or withdrawn after introduction in the market.
A Danish study published in the British Medical Journal in 2011 found women who took one of the newer types of Pill ran twice the risk of developing blood clots in the veins than those who used older-generation drugs.
Advertisement
Clots formed in the veins can break up and be transported to the heart or lungs and may be fatal.
In absolute terms, though, the risk is small, experts stress.
About 2.5 million women in France take the 3rd- and 4th-generation Pill, about half of all oral contraceptive users -- a statistic the French authorities judge excessive.
Touraine said she had asked the National Drugs Safety Agency (ANSM) to release safety data on the Pill and inform health professionals about giving priority to the older, second-generation Pill when prescribing.
The EMA said it had not received new evidence from "any member state" in relation to blood-clot risks, and promised that any information submitted to it would be reviewed promptly.
Under European rules, countries must accept medications that are approved by EMA but this does not prevent national authorities from making recommendations about how the drugs are used.
They are also allowed to temporarily suspend the drugs under the precautionary principle, but cannot ban them unilaterally.
The storm in France was triggered in part by the case of a 25-year-old woman, Marion Larat, who was left badly handicapped by a stroke that, in a lawsuit, she attributed to a later-generation pill made by German firm Bayer.
Her lawyer said in December that 30 other women are likely to file a suit targeting Schering, Merck and Pfizer as well as Bayer.
Some of the 3rd- and 4th-generation pills are already the target of lawsuits and tighter guidelines in the United States.
Last year, Bayer which makes the Yasmin and Yaz contraceptives, said it had spent $750 million to settle nearly 3,500 lawsuits for alleged deep-vein thrombosis or pulmonary embolism.
An estimated 3,800 more lawsuits remain to be settled, as well as nearly 5,000 other claims over other types of injuries allegedly caused by the pills.
In October last year, the US Food and Drug Administration (FDA) required Yasmin, Yaz and two other brands, Beyaz and Safyral, to carry labels warning of a higher risk of clots.
The risks are also influenced by smoking, obesity, diabetes and genes.
The French government has already announced the country's health system will no longer reimburse 3rd- and 4th-generation pills, a measure that will take effect on September 30.
Source-AFP
